StonvexLoading…
StonvexStonvexStonvexCore line items from IVHI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-119.31K | $-58.02K | $-47.96K | $-38.88K |
Net Income | $-119.31K | $-58.02K | $-47.96K | $-7.50K |
EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 |
Total Assets | $517.60K | $1.50K | $3.75K | $1.50K |
Total Liabilities | $507.83K | $63.65K | $55.84K | $48.95K |
Cash & Equivalents | $100.00 | $0.00 | $0.00 | $0.00 |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 100.96M | 100.52M | 100.52M | 100.52M |